Anders Ullén Selected Research

Anders Ullén Research Topics

Disease

22	Neoplasms (Cancer) 01/2024 - 02/2002
18	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2005
14	Carcinoma (Carcinomatosis) 09/2023 - 07/2013
10	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 09/2008
5	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2021
4	Disease Progression 09/2023 - 09/2011
3	Non-Muscle Invasive Bladder Neoplasms 12/2022 - 01/2022
2	Pathologic Constriction (Stenosis) 12/2022 - 10/2021
2	Urinary Tract Infections (Urinary Tract Infection) 12/2022 - 01/2022
2	Neutropenia 01/2019 - 12/2015
2	Circulating Neoplastic Cells 01/2019 - 11/2018
2	Febrile Neutropenia 01/2019 - 01/2018
2	Renal Cell Carcinoma (Grawitz Tumor) 06/2014 - 09/2011
1	Bone Fractures (Bone Fracture) 01/2023
1	Urologic Neoplasms (Urological Cancer) 01/2023
1	Thromboembolism 12/2022
1	Incisional Hernia 12/2022
1	Nocturia 10/2022
1	Diarrhea 01/2022
1	Hyponatremia 01/2019
1	Fatigue 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Microsatellite Instability 11/2018
1	Pain (Aches) 01/2018
1	Thrombocytopenia (Thrombopenia) 12/2015
1	Ovarian Neoplasms (Ovarian Cancer) 12/2015
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2007
1	Bone Resorption 01/2005

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2012
6	PlatinumIBA 09/2023 - 08/2016
5	avelumabIBA 09/2023 - 01/2020
4	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 07/2013
4	vinflunineIBA 01/2020 - 08/2016
4	Sorafenib (BAY 43-9006)FDA Link 01/2019 - 07/2010
4	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 01/2016
4	AndrogensIBA 01/2018 - 01/2005
3	Tyrosine Kinase InhibitorsIBA 01/2019 - 07/2010
2	Radium-223IBA 01/2023 - 01/2021
2	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 01/2020
2	Gemcitabine FDA Link 01/2020 - 01/2020
2	Zoledronic Acid (Zometa)FDA Link 01/2017 - 01/2005
2	melflufenIBA 01/2016 - 12/2015
2	Docetaxel (Taxotere)FDA Link 08/2015 - 01/2005
1	Immunoconjugates (Immunoconjugate)IBA 12/2023
1	pembrolizumabIBA 12/2023
1	Immune Checkpoint InhibitorsIBA 12/2023
1	Proteins (Proteins, Gene)FDA Link 10/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	Dihydrotachysterol (AT 10)IBA 10/2021
1	Alkaline PhosphataseIBA 01/2021
1	LigandsIBA 01/2020
1	Circulating Tumor DNAIBA 01/2019
1	enzalutamideIBA 01/2019
1	abirateroneIBA 01/2019
1	Cell-Free Nucleic AcidsIBA 11/2018
1	DNA (Deoxyribonucleic Acid)IBA 11/2018
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2018
1	cabazitaxel FDA Link 01/2018
1	Interleukin-2 (IL2)IBA 01/2017
1	Abiraterone AcetateIBA 08/2016
1	CarbonIBA 08/2016
1	Adenosine Triphosphate (ATP)IBA 01/2016
1	Dasatinib (BMS 354825)FDA Link 01/2016
1	Alkylating AgentsIBA 12/2015
1	AminopeptidasesIBA 12/2015
1	Melphalan (Alkeran)FDA LinkGeneric 12/2015
1	Peptide Hydrolases (Proteases)FDA Link 12/2015
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 11/2014
1	Bevacizumab (Avastin)FDA Link 09/2011
1	Sunitinib (Sutent)FDA Link 09/2011
1	InterferonsIBA 09/2011
1	Arsenic Trioxide (Trisenox)FDA Link 01/2007
1	Cytostatic AgentsIBA 01/2005
1	Hormones (Hormone)IBA 01/2005
1	Diphosphonates (Bisphosphonates)IBA 01/2005
1	Therapeutic UsesIBA 01/2005
1	Monoclonal AntibodiesIBA 02/2002
1	AntibodiesIBA 02/2002

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 01/2024 - 09/2008
12	Therapeutics 01/2023 - 01/2005
10	Cystectomy 01/2023 - 06/2012
10	Castration 01/2023 - 08/2015
8	Radiotherapy 12/2022 - 02/2002
7	Neoadjuvant Therapy 12/2022 - 06/2012
4	Brachytherapy 10/2022 - 01/2015
2	Immunotherapy 01/2022 - 07/2019
1	Nephroureterectomy 01/2024
1	Urinary Diversion (Ileal Conduit) 01/2023
1	Adjuvant Chemotherapy 04/2022
1	Aftercare (After-Treatment) 10/2021
1	Prostatectomy (Retropubic Prostatectomy) 01/2015